Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of chronic or relapsing COVID-19 in immunodeficiency.
Brown LK, Moran E, Goodman A, Baxendale H, Bermingham W, Buckland M, AbdulKhaliq I, Jarvis H, Hunter M, Karanam S, Patel A, Jenkins M, Robbins A, Khan S, Simpson T, Jolles S, Underwood J, Savic S, Richter A, Shields A, Brown M, Lowe DM. Brown LK, et al. Among authors: brown m. J Allergy Clin Immunol. 2022 Feb;149(2):557-561.e1. doi: 10.1016/j.jaci.2021.10.031. Epub 2021 Nov 12. J Allergy Clin Immunol. 2022. PMID: 34780850 Free PMC article.
Norovirus infection in primary immune deficiency.
Brown LK, Clark I, Brown JR, Breuer J, Lowe DM. Brown LK, et al. Among authors: brown jr. Rev Med Virol. 2017 May;27(3):e1926. doi: 10.1002/rmv.1926. Epub 2017 Mar 8. Rev Med Virol. 2017. PMID: 28271593 Review.
Mutagenesis in Norovirus in Response to Favipiravir Treatment.
Ruis C, Brown LK, Roy S, Atkinson C, Williams R, Burns SO, Yara-Romero E, Jacobs M, Goldstein R, Breuer J, Lowe DM. Ruis C, et al. Among authors: brown lk. N Engl J Med. 2018 Nov 29;379(22):2173-2176. doi: 10.1056/NEJMc1806941. N Engl J Med. 2018. PMID: 30485769 Free article. No abstract available.
A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.
Brown LK, Ruis C, Clark I, Roy S, Brown JR, Albuquerque AS, Patel SY, Miller J, Karim MY, Dervisevic S, Moore J, Williams CA, Cudini J, Moreira F, Neild P, Seneviratne SL, Workman S, Toumpanakis C, Atkinson C, Burns SO, Breuer J, Lowe DM. Brown LK, et al. Among authors: brown jr. J Allergy Clin Immunol. 2019 Nov;144(5):1450-1453. doi: 10.1016/j.jaci.2019.07.036. Epub 2019 Aug 13. J Allergy Clin Immunol. 2019. PMID: 31415785 Free PMC article. No abstract available.
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
Lowe DM, Brown LK, Chowdhury K, Davey S, Yee P, Ikeji F, Ndoutoumou A, Shah D, Lennon A, Rai A, Agyeman AA, Checkley A, Longley N, Dehbi HM, Freemantle N, Breuer J, Standing JF; FLARE Investigators. Lowe DM, et al. Among authors: brown lk. PLoS Med. 2022 Oct 19;19(10):e1004120. doi: 10.1371/journal.pmed.1004120. eCollection 2022 Oct. PLoS Med. 2022. PMID: 36260627 Free PMC article. Clinical Trial.
Surveillance for COVID-19-associated pulmonary aspergillosis.
Brown LK, Ellis J, Gorton R, De S, Stone N. Brown LK, et al. Lancet Microbe. 2020 Aug;1(4):e152. doi: 10.1016/S2666-5247(20)30091-4. Epub 2020 Aug 6. Lancet Microbe. 2020. PMID: 33521717 Free PMC article. No abstract available.
386 results